Home Overview Press Room Blog Publications For Students about us

Biotech & Pharma : Displaying 747-756 of 1520

FDA Report Faults Houston Stem-Cell Companyby Todd AckermanHouston ChronicleJune 26th, 2012The company involved in Gov. Rick Perry's unlicensed adult stem-cell procedure is rife with basic manufacturing problems, according to the US Food and Drug Administration.
Bodies with HistoriesThe New Search for the Biology of Raceby Anne Fausto-SterlingBoston ReviewJune 25th, 2012A lot of medical research money is now devoted to finding genetic differences between races that may explain health disparities, but many students of biology and race think that is a bad idea.
Informed Consent: A Broken Contractby Erika Check HaydenNature NewsJune 20th, 2012As large-scale genetic research has become faster and cheaper, more and more personal genetic data collected for one purpose ends up being used for another.
Genetic Testing For Color Vision Makes Commercial Debut for Military Applicationsby Dan BucklandmedGadgetJune 12th, 2012Possibly heralding a new era in the use of genetic testing for hiring decisions, Genevolve recently announced a new “military grade” test for inherited color blindness.
Personal-Genetics Company Patent Raises Hacklesby Monya BakerNature News BlogMay 31st, 2012The personal genetics company 23andMe announced its first patent filing yesterday. Clients expressed their concern and dismay on the company's website.
Race Under the Microscope: A New Video by the Center for Genetics and Societyby Emily BeitiksBiopolitical TimesMay 31st, 2012A new video by the Center for Genetics and Society explores how genetic research and its commercial by-products are reviving harmful and false assumptions about race.
In the News: Stem Cell Cash Will Run Out – Then What?by David JensenThe Sacramento BeeMay 20th, 2012Prop. 71 has previously provided a direct stream of state bond cash, but what will happen when, in about five years, the state stops borrowing money to finance stem cell research?
California Considers DNA Privacy Lawby Helen ShenNatureMay 18th, 2012California lawmakers are considering a bill that would require written consent for the collection, retention, and sharing of individual genetic information. Academic researchers fear the measures would prohibit work with genetic databases.
Many Rare Mutations May Underpin Diseasesby Nicholas WadeThe New York TimesMay 17th, 2012Given new data, finding the genetic roots of common disease seems much harder, dimming the promise of personal genomics and the chances of quick medical payoffs from the human genome project.
Big Promises Backed by Bad Theoryby Eric Hoffman and Stuart NewmanGenetic Engineering & Biotechnology NewsMay 15th, 2012Synthetic biology is not only based on poor biological models, but also presents dramatic risks to health and the environment. The field is badly in need of oversight and regulation.
Displaying 747-756 of 1520  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760